Deepcure is using AI to build an engine for small molecule drug discovery. With their team of experienced scientists and engineers, Deepcure is optimizing all phases of drug discovery from early hit identification, lead optimization to patent strategy and IND filing preparation. The aim is to yield short timelines in the development of the highest-quality drug candidates. To achieve this, Deepcure is using their intelligent AI funnel comprising their proprietary molecular database, MolDB, a collection of 10^18 synthesizable molecules, to cover chemical space and search for medicinal chemistry compounds. MolDB enables the discovery of compounds that don’t exist in traditional screening libraries, putting Deepcure at an advantage for pursuing each of their discovery programs.

DeepCure

Founded: 2018
Location: Boston, MA
Employee range: 11 - 50
Funding: $40M A Nov 2021

Short description:

Drug notes:

Long description:

Jobs: